Supera Self-expanding Stents for Endovascular Treatment of Femoropopliteal Disease: The Clinical Evidence - George Adams, MD, MHS

↳ This is a section part of Moment: CRT 2016 Endovascular - Advantages and Indications for the Supera Stent

Add this Moment to your Passport

Learn from this moment and keep it forever.
No longer available for purchase

Preview

Summary

Supera Self-expanding Stents for Endovascular Treatment of Femoropopliteal Disease: The Clinical Evidence presented by George Adams, MD, MHS at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
No longer available for purchase

Target Audience

  • Interventional Cardiologists
  • Vascular Surgeons
  • Interventional Radiologists
  • Interventional Fellows

Sponsored by Abbott Vascular

Session Name: Advantages and Indications for the Supera Stent (NON-CME)

Track: CRT 2016 Endovascular

Learning Objectives

Update in advances in endovascular procedures

Other Components in this Moment

Overview
Supera Self-expanding Stents for Endovascular Treatment of Femoropopliteal Disease: The Clinical Evidence - George Adams, MD, MHS
Live Case #2 from MedStar Washington Hospital Center - Washington, DC
Loading Simple Education